AKCEA THERAPEUTICS, INC. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Services Agreements (3)
- Voting Agreements (1)
- Strategic Advisory Services Agreement, by and between Registrant and B. Lynne Parshall dated, January 9, 2020 (Filed With SEC on May 6, 2020)
- Amendment No. 1 to the Strategic Collaboration, Option and License Agreement between the Registrant and Novartis Pharma AG dated February 22, 2019 (Filed With SEC on May 9, 2019)
- Collaboration and License Agreement dated August 1, 2018 by and between Akcea Therapeutics, Inc. and PTC Therapeutics International Limited (Filed With SEC on November 6, 2018)
- Stockholder Voting Agreement, dated March 14, 2018, by and between Akcea Therapeutics, Inc. and Novartis Pharma AG (Filed With SEC on March 15, 2018)
- Amended and Restated Services Agreement, dated March 14, 2018, by and between Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc (Filed With SEC on March 15, 2018)
- Development, Commercialization, Collaboration and License Agreement, dated March 14, 2018, by and between Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc (Filed With SEC on March 15, 2018)
- STRATEGIC COLLABORATION, OPTION AND LICENSE AGREEMENT BETWEEN AKCEA THERAPEUTICS, INC. AND NOVARTIS PHARMA AG (Filed With SEC on April 10, 2017)
- STRATEGIC COLLABORATION, OPTION AND LICENSE AGREEMENT BETWEEN AKCEA THERAPEUTICS, INC. AND NOVARTIS PHARMA AG (Filed With SEC on March 27, 2017)
- SERVICES AGREEMENT (Filed With SEC on March 27, 2017)
